Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sandra M Herrmann

Showing results (1-10 of 97) with videos related to

Pageof 10
Sort By:
Journal of the National Comprehensive Cancer Network : JNCCN|November 10, 2025
Proton Pump Inhibitors in the Era of Immunotherapy: A Risk Worth Taking?Sandra M Herrmann
American Journal of Nephrology|January 6, 2026
Uptodate on Onconephrology: Navigating Kidney Challenges in Patients with CancerSandra M Herrmann
Kidney360|September 21, 2022
Is Rechallenge Appropriate in Patients that Develop Immune Checkpoint Inhibitor-Associated AKI?: PROSandra M Herrmann
Clinical Kidney Journal|November 2, 2023
Immune checkpoint inhibitors and their interaction with proton pump inhibitors-related interstitial nephritisJing Miao, Sandra M Herrmann
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|June 12, 2021
Capmatinib-Induced Pseudo-Acute Kidney Injury: A Case ReportArjunmohan Mohan, Sandra M Herrmann
Kidney Medicine|May 1, 2023
Immune Checkpoint Inhibitor-Associated Sarcoidosis Reaction in the Kidney: Case ReportMariam Charkviani, Sandra M Herrmann
American Journal of Hypertension|October 7, 2017
Current Concepts in the Treatment of Renovascular HypertensionSandra M Herrmann, Stephen C Textor
Kidney International Reports|August 11, 2020
Immune Checkpoint Inhibitors and Immune-Related Adverse Renal EventsSandra M Herrmann, Mark A Perazella
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|May 25, 2017
Evidence and Renovascular Disease: Trials and Mistrials?Stephen C Textor, Sandra M Herrmann
Endocrinology and Metabolism Clinics of North America|October 28, 2019
Renovascular HypertensionSandra M Herrmann, Stephen C Textor
Pageof 10

Showing results (1-10 of 97) with videos related to

Sort By:
Pageof 10
Journal of the National Comprehensive Cancer Network : JNCCN|November 10, 2025
Proton Pump Inhibitors in the Era of Immunotherapy: A Risk Worth Taking?Sandra M Herrmann
American Journal of Nephrology|January 6, 2026
Uptodate on Onconephrology: Navigating Kidney Challenges in Patients with CancerSandra M Herrmann
Kidney360|September 21, 2022
Is Rechallenge Appropriate in Patients that Develop Immune Checkpoint Inhibitor-Associated AKI?: PROSandra M Herrmann
Clinical Kidney Journal|November 2, 2023
Immune checkpoint inhibitors and their interaction with proton pump inhibitors-related interstitial nephritisJing Miao, Sandra M Herrmann
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|June 12, 2021
Capmatinib-Induced Pseudo-Acute Kidney Injury: A Case ReportArjunmohan Mohan, Sandra M Herrmann
Kidney Medicine|May 1, 2023
Immune Checkpoint Inhibitor-Associated Sarcoidosis Reaction in the Kidney: Case ReportMariam Charkviani, Sandra M Herrmann
American Journal of Hypertension|October 7, 2017
Current Concepts in the Treatment of Renovascular HypertensionSandra M Herrmann, Stephen C Textor
Kidney International Reports|August 11, 2020
Immune Checkpoint Inhibitors and Immune-Related Adverse Renal EventsSandra M Herrmann, Mark A Perazella
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|May 25, 2017
Evidence and Renovascular Disease: Trials and Mistrials?Stephen C Textor, Sandra M Herrmann
Endocrinology and Metabolism Clinics of North America|October 28, 2019
Renovascular HypertensionSandra M Herrmann, Stephen C Textor
Pageof 10